nRichDX Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Latest Deal Amount
  • $20M

  • Investors
  • 1

nRichDX General Information

Description

Developer of a medical device designed to be engineered specifically for liquid biopsy applications. The company's system is designed to extract genetic target material from bodily fluids such as blood, plasma, urine, and pleural fluid, high-yield, high-recovery, IVD-labeled sample prep platforms capable of processing plasma or urine sample volumes in a single extraction, unlike other methods, it does not require yield-lowering eluate pooling or sample transfer steps, thereby helping healthcare companies to improve workflow, greatly enhancing test sensitivity and producing consistently reliable test results while increasing revenue and reducing operational costs and complexity.

Contact Information

Website
www.nrichdx.com
Formerly Known As
WaveSense
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 15339 Barranca Parkway
  • Irvine, CA 92618
  • United States
+1 (949)
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Biotechnology
Vertical(s)
Nanotechnology, Manufacturing, Life Sciences, Oncology
Corporate Office
  • 15339 Barranca Parkway
  • Irvine, CA 92618
  • United States
+1 (949)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

nRichDX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) $20M Upcoming Generating Revenue/Not Profitable
6. Later Stage VC 30-Dec-2023 Completed Generating Revenue/Not Profitable
5. Later Stage VC 17-Jun-2020 Completed Generating Revenue
4. Later Stage VC 19-Nov-2019 Completed Generating Revenue
3. Later Stage VC 30-Oct-2017 Completed Generating Revenue
2. Later Stage VC 01-May-2016 $2.33M $4.58M Completed Generating Revenue
1. Later Stage VC 16-Jul-2015 $2.25M $2.25M Completed Startup
To view nRichDX’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

nRichDX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical device designed to be engineered specifically for liquid biopsy applications. The company's syste
Diagnostic Equipment
Irvine, CA
25 As of 2024

Huntingdon Valley, PA

Hilden, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

nRichDX Competitors (4)

One of nRichDX’s 4 competitors is CellSearch, a Corporate Backed or Acquired company based in Huntingdon Valley, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CellSearch Corporate Backed or Acquired Huntingdon Valley, PA
Qiagen Formerly VC-backed Hilden, Germany
Promega Formerly PE-Backed Madison, WI
Thermo Fisher Scientific Formerly PE-Backed Waltham, MA
To view nRichDX’s complete competitors history, request access »

nRichDX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

nRichDX Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Signatures Capital Venture Capital Minority
To view nRichDX’s complete investors history, request access »

Ready to get started?

Request a free trial

nRichDX FAQs

  • When was nRichDX founded?

    nRichDX was founded in 2005.

  • Where is nRichDX headquartered?

    nRichDX is headquartered in Irvine, CA.

  • What is the size of nRichDX?

    nRichDX has 25 total employees.

  • What industry is nRichDX in?

    nRichDX’s primary industry is Diagnostic Equipment.

  • Is nRichDX a private or public company?

    nRichDX is a Private company.

  • What is nRichDX’s current revenue?

    The current revenue for nRichDX is .

  • How much funding has nRichDX raised over time?

    nRichDX has raised $19M.

  • Who are nRichDX’s investors?

    Signatures Capital has invested in nRichDX.

  • Who are nRichDX’s competitors?

    CellSearch, Qiagen, Promega, and Thermo Fisher Scientific are competitors of nRichDX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »